271 related articles for article (PubMed ID: 5093939)
21. [A case of Lasch--Nyhan syndrome (total deficiency of hypoxanthine-guanine phosphoribosyltransferase)].
Schmidt R; Mundel G; Sperling O
Harefuah; 1972 May; 82(9):410-3. PubMed ID: 5041217
[No Abstract] [Full Text] [Related]
22. Metabolic implications of the Lesch-Nyhan syndrome.
Emmerson BT
Aust N Z J Med; 1972 Feb; 2(1):88-90. PubMed ID: 4502722
[No Abstract] [Full Text] [Related]
23. Hyperuricemia and mental retardation with athetosis and self-mutilation.
Michener WM
Am J Dis Child; 1967 Feb; 113(2):195-206. PubMed ID: 6019435
[No Abstract] [Full Text] [Related]
24. Biochemical and genetic studies of an X-linked neurological disease (The Lesch-Nyhan syndrome).
Seegmiller JE
Harvey Lect; 1971; 65():175-92. PubMed ID: 4945433
[No Abstract] [Full Text] [Related]
25. Seminars on Lesch-Nyhan syndrome. Aspects of purine metabolism.
Balis ME
Fed Proc; 1968; 27(4):1067-74. PubMed ID: 4968794
[No Abstract] [Full Text] [Related]
26. Plasma and urinary oxypurines in Lesch-Nyhan patient after allopurinol treatment.
Roscioni G; Farnetani MA; Pagani R; Pizzichini M; Marinello E; Porcelli B
Adv Exp Med Biol; 1994; 370():357-61. PubMed ID: 7660928
[No Abstract] [Full Text] [Related]
27. Treatment of Lesch-Nyhan syndrome with AICAR.
Page T; Barshop B; Yu AL; Nyhan WL
Adv Exp Med Biol; 1994; 370():353-6. PubMed ID: 7660927
[No Abstract] [Full Text] [Related]
28. Urinary metabolites in congenital hyperuricosuria.
Balis ME; Krakoff IH; Berman PH; Dancis J
Science; 1967 May; 156(3778):1122-3. PubMed ID: 6024192
[TBL] [Abstract][Full Text] [Related]
29. Detection of females heterozygous for the Lesch-Nyhan mutation by 8-azaguanine-resistant growth of cultured fibroblasts.
Felix JS; DeMars R
J Lab Clin Med; 1971 Apr; 77(4):596-604. PubMed ID: 4252001
[No Abstract] [Full Text] [Related]
30. Lesch-Nyhan syndrome. Management and treatment.
Seegmiller JE
Fed Proc; 1968; 27(4):1097-104. PubMed ID: 4298065
[No Abstract] [Full Text] [Related]
31. Treatment of gout and hyperuricaemia by benzbromarone, ethyl 2 (dibromo-3,5 hydroxy-4 benzoyl)-3 benzofuran.
de Gery A; Auscher C; Saporta L; Delbarre F
Adv Exp Med Biol; 1974; 41():683-9. PubMed ID: 4598966
[No Abstract] [Full Text] [Related]
32. Clinical features of the Lesch-Nyhan syndrome. Introduction--clinical and genetic features.
Nyhan WL
Fed Proc; 1968; 27(4):1027-33. PubMed ID: 5658468
[No Abstract] [Full Text] [Related]
33. Efficacy and safety of allopurinol in patients with the Lesch-Nyhan syndrome and partial hypoxanthine- phosphoribosyltransferase deficiency: a follow-up study of 18 Spanish patients.
Torres RJ; Prior C; Puig JG
Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1077-82. PubMed ID: 17065067
[TBL] [Abstract][Full Text] [Related]
34. The urinary excretion of aminoimidazolecarboxamide in the Lesch-Nyhan syndrome.
Newcombe DS
Pediatrics; 1970 Oct; 46(4):508-12. PubMed ID: 5503686
[No Abstract] [Full Text] [Related]
35. Excretion of hypoxanthine and xanthine in a genetic disease of purine metabolism.
Sweetman L; Nyhan WL
Nature; 1967 Aug; 215(5103):859-60. PubMed ID: 6049739
[No Abstract] [Full Text] [Related]
36. Alteration of purine control mechanisms in patients with the Lesch-Nyhan mutation.
Benke PJ
Wis Med J; 1971 Jul; 70(7):174-5. PubMed ID: 5560233
[No Abstract] [Full Text] [Related]
37. Urinary xanthine stones--a rare complication of allopurinol therapy.
Greene ML; Fujimoto WY; Seegmiller JE
N Engl J Med; 1969 Feb; 280(8):426-7. PubMed ID: 5763090
[No Abstract] [Full Text] [Related]
38. [Xanthinuria (author's transl)].
Cartier P; Perignon JL
Nouv Presse Med; 1978 Apr; 7(16):1381-90. PubMed ID: 673672
[TBL] [Abstract][Full Text] [Related]
39. Lesch-Nyhan syndrome. Summary of clinical features.
Nyhan WL
Fed Proc; 1968; 27(4):1034-41. PubMed ID: 5658469
[No Abstract] [Full Text] [Related]
40. A screening technique for the Lesch-Nyhan syndrome.
Jenkins EC
J Pediatr; 1971 Oct; 79(4):663-6. PubMed ID: 5094259
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
